Literature DB >> 22477086

Mapping the risk of yellow Fever infection.

David R Hill1.   

Abstract

The World Health Organization coordinated a comprehensive, systematic review of the countries and areas at risk for yellow fever (YF) virus transmission. The review applied the following evidence to each country and area considered: human and non-human YF cases, human serology for anti-YF antibody obtained prior to widespread YF vaccination, altitude, vegetation, and vector distribution. The result was the categorization of countries or areas as endemic, transitional, low potential for infection, or no risk. This information was adapted to create a map that defined the areas where vaccination against YF may be recommended. Travel health professionals, countries, and public health bodies can use this information as they determine recommendations and requirements for vaccination. This paper reviews the process and outcomes of the review of YF risk, and places it in the context of providing YF vaccination.

Entities:  

Year:  2012        PMID: 22477086     DOI: 10.1007/s11908-012-0256-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  44 in total

1.  Outbreak news. Yellow fever, Paraguay.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2008-03-21

2.  SUSCEPTIBILITY OF WHITE MICE TO THE VIRUS OF YELLOW FEVER.

Authors:  M Theiler
Journal:  Science       Date:  1930-04-04       Impact factor: 47.728

Review 3.  Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

Authors:  Alan D T Barrett; Dirk E Teuwen
Journal:  Curr Opin Immunol       Date:  2009-06-10       Impact factor: 7.486

4.  Dynamic behavior of sylvatic yellow fever in Brazil (1954-2008).

Authors:  Fernando Portela Câmara; Ana Luisa Bessa Bacellar Gomes; Luiz Max Fagundes de Carvalho; Luiz Gustavo Veloso Castello
Journal:  Rev Soc Bras Med Trop       Date:  2011-04-29       Impact factor: 1.581

5.  Yellow fever in Africa and Central and South America, 2008–2009.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2011-01-21

6.  Hepatitis and death following vaccination with 17D-204 yellow fever vaccine.

Authors:  R C Chan; D J Penney; D Little; I W Carter; J A Roberts; W D Rawlinson
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

7.  Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-08-03       Impact factor: 17.586

8.  Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.

Authors:  Kitisak Kengsakul; Kriengkrai Sathirapongsasuti; Sompone Punyagupta
Journal:  J Med Assoc Thai       Date:  2002-01

9.  Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes.

Authors:  Bali Pulendran; Joseph Miller; Troy D Querec; Rama Akondy; Nelson Moseley; Oscar Laur; John Glidewell; Nathan Monson; Tuofu Zhu; Haiying Zhu; Sylvija Staprans; David Lee; Margo A Brinton; Andrey A Perelygin; Claudia Vellozzi; Philip Brachman; Susan Lalor; Dirk Teuwen; Rachel B Eidex; Marty Cetron; Frances Priddy; Carlos del Rio; John Altman; Rafi Ahmed
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

10.  Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study.

Authors:  Anna H Roukens; Darius Soonawala; Simone A Joosten; Adriëtte W de Visser; Xiaohong Jiang; Kees Dirksen; Marjolein de Gruijter; Jaap T van Dissel; Peter J Bredenbeek; Leo G Visser
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

View more
  4 in total

1.  Predicting Yellow Fever Through Species Distribution Modeling of Virus, Vector, and Monkeys.

Authors:  Marco A B de Almeida; Edmilson Dos Santos; Jáder da C Cardoso; Lucas G da Silva; Rafael M Rabelo; Júlio César Bicca-Marques
Journal:  Ecohealth       Date:  2018-12-17       Impact factor: 3.184

2.  Frog skin cultures secrete anti-yellow fever compounds.

Authors:  Carolina Muñoz-Camargo; Margarita Correa Méndez; Vivian Salazar; Johanna Moscoso; Diana Narváez; Maria Mercedes Torres; Franz Kaston Florez; Helena Groot; Eduardo Mitrani
Journal:  J Antibiot (Tokyo)       Date:  2016-04-06       Impact factor: 2.649

Review 3.  Yellow fever vaccine-associated viscerotropic disease: current perspectives.

Authors:  Roger E Thomas
Journal:  Drug Des Devel Ther       Date:  2016-10-12       Impact factor: 4.162

4.  Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic.

Authors:  Hea Yoon Kwon; HyeJin Lee; Jae Hyoung Im; Shin Goo Park; Yeon Ji Lee; Ji Hyeon Baek; Jin Soo Lee
Journal:  J Korean Med Sci       Date:  2019-08-26       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.